Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OUTPATIENT RX DRUG USE AMONG MEDICARE BENEFICIARIES

Executive Summary

OUTPATIENT RX DRUG USE AMONG MEDICARE BENEFICIARIES is collected in an HHS survey of 14,000 households. The study is being conducted by the HHS National Center for Health Statistics Research Office of Intramural Research. Each household was interviewed roughly five times over the course of 18 months, according to HHS staff. Data was collected on what drugs were prescribed and why, who paid for the drugs and how much they cost. The report is not expected to reach the secretary level at HHS before April 15, where it will be approved before being forwarded to Capitol Hill. The department had initially hoped to meet the April 1 deadline for submission to Congress ("The Pink Sheet" March 6, T&G-1). Required by the Catastrophic Care Act, the survey will provide a basis for Congressional Budget Office estimates on the cost of the new Medicare outpatient drug benefit. The full Rx benefit is scheduled to start up in 1991. The study is based on data collected as part of the National Medical Expenditure Survey (NMES), a comprehensive measure of U.S. spending on health care goods and services for calendar year 1987.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS015351

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel